197 related articles for article (PubMed ID: 29484131)
1. Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.
Tsoli M; Liu J; Franshaw L; Shen H; Cheng C; Jung M; Joshi S; Ehteda A; Khan A; Montero-Carcabosso A; Dilda PJ; Hogg P; Ziegler DS
Oncotarget; 2018 Jan; 9(7):7541-7556. PubMed ID: 29484131
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
3. Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity.
Asby DJ; Killick-Cole CL; Boulter LJ; Singleton WG; Asby CA; Wyatt MJ; Barua NU; Bienemann AS; Gill SS
Cancer Manag Res; 2018; 10():3483-3500. PubMed ID: 30254491
[TBL] [Abstract][Full Text] [Related]
4. Dual Inhibition of PI3K/AKT and MEK/ERK Pathways Induces Synergistic Antitumor Effects in Diffuse Intrinsic Pontine Glioma Cells.
Wu YL; Maachani UB; Schweitzer M; Singh R; Wang M; Chang R; Souweidane MM
Transl Oncol; 2017 Apr; 10(2):221-228. PubMed ID: 28189993
[TBL] [Abstract][Full Text] [Related]
5. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
[TBL] [Abstract][Full Text] [Related]
6. Polo-like Kinase 1 as a potential therapeutic target in Diffuse Intrinsic Pontine Glioma.
Amani V; Prince EW; Alimova I; Balakrishnan I; Birks D; Donson AM; Harris P; Levy JM; Handler M; Foreman NK; Venkataraman S; Vibhakar R
BMC Cancer; 2016 Aug; 16():647. PubMed ID: 27538997
[TBL] [Abstract][Full Text] [Related]
7. BMI-1 is a potential therapeutic target in diffuse intrinsic pontine glioma.
Kumar SS; Sengupta S; Lee K; Hura N; Fuller C; DeWire M; Stevenson CB; Fouladi M; Drissi R
Oncotarget; 2017 Sep; 8(38):62962-62975. PubMed ID: 28968963
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-Loaded Gold Nanoarchitectures as a Therapeutic Strategy against Diffuse Intrinsic Pontine Glioma.
Ung C; Tsoli M; Liu J; Cassano D; Pocoví-Martínez S; Upton DH; Ehteda A; Mansfeld FM; Failes TW; Farfalla A; Katsinas C; Kavallaris M; Arndt GM; Vittorio O; Cirillo G; Voliani V; Ziegler DS
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33805713
[TBL] [Abstract][Full Text] [Related]
9.
Kluiver TA; Alieva M; van Vuurden DG; Wehrens EJ; Rios AC
Front Oncol; 2020; 10():92. PubMed ID: 32117746
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.
Halvorson KG; Barton KL; Schroeder K; Misuraca KL; Hoeman C; Chung A; Crabtree DM; Cordero FJ; Singh R; Spasojevic I; Berlow N; Pal R; Becher OJ
PLoS One; 2015; 10(3):e0118926. PubMed ID: 25748921
[TBL] [Abstract][Full Text] [Related]
11. Intersection of Brain Development and Paediatric Diffuse Midline Gliomas: Potential Role of Microenvironment in Tumour Growth.
Loveson KF; Fillmore HL
Brain Sci; 2018 Nov; 8(11):. PubMed ID: 30453529
[TBL] [Abstract][Full Text] [Related]
12. Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma.
Zhang Y; Dong W; Zhu J; Wang L; Wu X; Shan H
Cell Biosci; 2017; 7():56. PubMed ID: 29118968
[TBL] [Abstract][Full Text] [Related]
13. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
14. Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG).
Dai L; Chen J; Lin Z; Wang Z; Mu S; Qin Z
J Cancer; 2020; 11(16):4683-4691. PubMed ID: 32626514
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.
Zarghooni M; Bartels U; Lee E; Buczkowicz P; Morrison A; Huang A; Bouffet E; Hawkins C
J Clin Oncol; 2010 Mar; 28(8):1337-44. PubMed ID: 20142589
[TBL] [Abstract][Full Text] [Related]
16. Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event.
Koschmann C; Farooqui Z; Kasaian K; Cao X; Zamler D; Stallard S; Venneti S; Hervey-Jumper S; Garton H; Muraszko K; Franchi L; Robertson PL; Leonard M; Opipari V; Castro MG; Lowenstein PR; Chinnaiyan A; Mody R
NPJ Precis Oncol; 2017; 1(1):32. PubMed ID: 29872713
[TBL] [Abstract][Full Text] [Related]
17. Cutting Edge Therapeutic Insights Derived from Molecular Biology of Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG).
Bailey CP; Figueroa M; Mohiuddin S; Zaky W; Chandra J
Bioengineering (Basel); 2018 Oct; 5(4):. PubMed ID: 30340362
[TBL] [Abstract][Full Text] [Related]
18. DIPG in Children - What Can We Learn from the Past?
Vanan MI; Eisenstat DD
Front Oncol; 2015; 5():237. PubMed ID: 26557503
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience.
Del Baldo G; Carai A; Abbas R; Cacchione A; Vinci M; Di Ruscio V; Colafati GS; Rossi S; Diomedi Camassei F; Maestro N; Temelso S; Pericoli G; De Billy E; Giovannoni I; Carboni A; Rinelli M; Agolini E; Mackay A; Jones C; Chiesa S; Balducci M; Locatelli F; Mastronuzzi A
Ther Adv Med Oncol; 2022; 14():17588359221113693. PubMed ID: 36090803
[TBL] [Abstract][Full Text] [Related]
20. Functionally defined therapeutic targets in diffuse intrinsic pontine glioma.
Grasso CS; Tang Y; Truffaux N; Berlow NE; Liu L; Debily MA; Quist MJ; Davis LE; Huang EC; Woo PJ; Ponnuswami A; Chen S; Johung TB; Sun W; Kogiso M; Du Y; Qi L; Huang Y; Hütt-Cabezas M; Warren KE; Le Dret L; Meltzer PS; Mao H; Quezado M; van Vuurden DG; Abraham J; Fouladi M; Svalina MN; Wang N; Hawkins C; Nazarian J; Alonso MM; Raabe EH; Hulleman E; Spellman PT; Li XN; Keller C; Pal R; Grill J; Monje M
Nat Med; 2015 Jun; 21(6):555-9. PubMed ID: 25939062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
